BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35234826)

  • 1. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
    Mosallaei D; Hao M; Antaya RJ; Levian B; Kwong A; Cogan J; Hamilton C; Schwieger-Briel A; Tan C; Tang X; Woodley DT; Chen M
    JAMA Dermatol; 2022 Apr; 158(4):366-374. PubMed ID: 35234826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
    Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
    Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous gentamicin therapy induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients: An open label clinical trial.
    Woodley DT; Hao M; Kwong A; Levian B; Cogan J; Hou Y; Mosallaei D; Kleinman E; Zheng K; Chung C; Kim G; Peng D; Chen M
    Br J Dermatol; 2024 Feb; ():. PubMed ID: 38366625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin induces
    Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of Severe Generalized Junctional Epidermolysis Bullosa by Systemic Treatment with Gentamicin.
    Hammersen J; Neuner A; Wild F; Schneider H
    Dermatology; 2019; 235(4):315-322. PubMed ID: 31132778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
    Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
    J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
    Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G
    Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants.
    Martínez-Santamaría L; Maseda R; de Arriba MDC; Membrilla JA; Sigüenza AI; Mascías J; García M; Quintana L; Esteban-Rodríguez I; Hernández-Fernández CP; Illera N; Duarte B; Guerrero-Aspizúa S; Woodley DT; Del Río M; de Lucas R; Larcher F; Escámez MJ
    JAMA Dermatol; 2022 Apr; 158(4):439-443. PubMed ID: 35234827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
    Jeon IK; Kim SE; Kim SC
    J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa.
    Christiano AM; Pulkkinen L; Eady RA; Uitto J
    J Invest Dermatol; 1996 Apr; 106(4):775-7. PubMed ID: 8618020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm.
    Condorelli AG; Fortugno P; Cianfarani F; Proto V; Di Zenzo G; Didona B; Zambruno G; Castiglia D
    Br J Dermatol; 2018 Jun; 178(6):1416-1422. PubMed ID: 28561256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity for nonsense ans missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa.
    McGarth JA; Christiano AM; Pulkkinen L; Eady RA; Uitto J
    J Invest Dermatol; 1996 May; 106(5):1157-9. PubMed ID: 8618058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.
    Keith AR; Twaroski K; Ebens CL; Tolar J
    Expert Opin Biol Ther; 2020 Aug; 20(8):911-923. PubMed ID: 32178539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant splicing as potential modifier of the phenotype of junctional epidermolysis bullosa.
    Mittwollen R; Wohlfart S; Park J; Grosch E; Has C; Hohenester E; Schneider H; Hammersen J
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2127-2134. PubMed ID: 32124492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel LAMA3 mutation in a newborn with junctional epidermolysis bullosa herlitz type.
    Mazzucchelli I; Garofoli F; Decembrino L; Castiglia D; Tadini G; Bellingeri A; Borghesi A; Tzialla C; Manzoni P; Stronati M
    Neonatology; 2011; 99(3):188-91. PubMed ID: 20881434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.
    Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J
    Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent laminin 5 mutation in British patients with lethal (Herlitz) junctional epidermolysis bullosa: evidence for a mutational hotspot rather than propagation of an ancestral allele.
    Ashton GH; Mellerio JE; Dunnill MG; Pulkkinen L; Christiano AM; Uitto J; Eady RA; McGrath JA
    Br J Dermatol; 1997 May; 136(5):674-7. PubMed ID: 9205497
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.